Food & alt-protein

Layer-by-layer extrusion of food inks, laser-fixed in place as they print, paired with vision-guided robot arms that fry, wok-stir and plate the result — turning plant-based flank steak, dysphagia-friendly purees and fast-food fry stations into a precision digital pipeline instead of manual cooking.

B2B standardized botanical and functional-mushroom extracts — beta-glucans, hericenones, withanolides — produced by submerged fermentation, subcritical water extraction and lyophilization for the global adaptogen and legal-entheogen nutraceutical market.

Chlorella, spirulina and specialty microalgae strains are being processed into functional protein isolates and pigmented ingredients for bakery, meat-analogue and nutraceutical food applications — distinct from the omega-3-lipid-focused microalgae-for-aquafeed industry.

Bee-free honey produced ex vivo by precision fermentation: recombinant bee enzymes (invertase, glucose oxidase) expressed in Pichia pastoris convert a blended plant-sugar and phytochemical base into a vegan, hypoallergenic honey chemically identical to the natural product.

Plant-based and fermentation-derived protein sources designed to replicate the sensory and nutritional profiles of animal products.

Precision-fermented hydrocolloids — xanthan, gellan, welan and pullulan — grown by bacteria on corn syrup or molasses instead of extracted from guar beans or animal gelatin, delivering pseudoplastic thickening for food, cosmetics and drilling fluids without the climate-driven supply volatility of crop-based gums.

Fermentation-produced lysine, methionine, threonine and tryptophan let feed formulators hit exact amino-acid targets with lower-protein diets, cutting nitrogen excretion — a mature, price-cyclical commodity market where a single producer's price move (Evonik's 2026 MetAMINO increase) ripples through the whole value chain.

Enzymes and controlled fermentation are neutralizing the phytate, trypsin inhibitors and oligosaccharides that limit nutrient uptake from plant-based feed — an EU-authorized next-generation phytase, a fermented-soy process cutting risk on batch-to-batch antinutrient variability, and a Chinese phytase producer trimming manure phosphorus by up to 60%.

Prebiotic sodas, kombucha and cold-pressed wellness shots have moved from health-food-store niche to mainstream beverage aisle — PepsiCo's nearly $2 billion acquisition of Poppi is the clearest signal that gut-health functional beverages are now core, not adjacent, to incumbent beverage strategy.

Gummies, chewable tablets and chocolate carrying a defined colony-forming-unit dose of live probiotic strains — the supplement format that removes pill fatigue and swallowing barriers while remaining shelf-stable, now the fastest-growing segment of the digestive-health aisle.

A US policy push to phase out synthetic dyes is pulling fermentation-derived and plant-extracted natural colors from niche to mainstream — Sensient is investing up to $250M to expand capacity, and fermentation originators Chromologics and Michroma are scaling fungal pigments engineered to match synthetic-dye performance.

AI-discovered short amino-acid chains released from plant and animal proteins by directed enzymatic hydrolysis — a stack from in-silico screening to a purified, GRAS-grade functional ingredient for sports, longevity and clinical nutrition.

Brewing and distillation capacity (250–500 m³ tanks) is being repurposed as a fermentation CDMO platform for recombinant proteins — from beer and spirits to collagen and albumin.

Engineered-microbe cell factories and flavor-house biotech platforms producing flavors and fragrances — fermented vanillin, biosynthetic terpenes and natural-certified fruity molecules — via precision fermentation rather than petrochemicals or extraction.

True animal cell culture — growing adipose (fat) cells rather than fermenting a microbial host — reached a first regulatory milestone in 2025 when Mission Barns won USDA and FDA sign-off for cultivated pork fat, even as a UK cell-culture originator went into administration.

Beanless coffee made by fermenting non-tropical ingredients has already reached cafes on two continents, while true cell-cultured coffee grown in bioreactors — using 98% less water than farming — targets a first commercial product by 2027, addressing a crop increasingly threatened by climate change.

Genuine animal muscle and fat tissue grown from starter cells in bioreactors, decoupling meat from livestock while cutting the land, water and climate footprint of conventional husbandry.

Cell-cultured and precision-fermented animal proteins are entering pet food ahead of human food in several markets — the UK became the first European country to approve cultivated meat for sale, in pet food, in 2024.

Genuine fish, crustacean and mollusc tissue grown from fish cells in bioreactors, offering sushi-grade seafood without fishing pressure on wild stocks or the feed-fish burden of aquaculture.

Wet milling and enzymatic hydrolysis convert corn and wheat into maltodextrin, glucose syrups, modified starches and fermentation-derived feed amino acids (lysine, threonine), replacing petrochemical and animal-protein inputs across food, feed and industrial B2B supply chains.

Enzyme cocktails replace emulsifiers in bakery, accelerate cheese and charcuterie ripening, and improve plant-based meat texture — a mature specialty-enzyme industry where a profitable, publicly traded Indian originator sits alongside a Danish biosolutions leader and a Spanish ripening-enzyme launch.

Engineered enzymes and enzyme-target inhibitors are moving toward pharmaceutical protection from gluten exposure in celiac disease — a Barcelona-designed gastric enzyme validated in mouse models, a transglutaminase-2 inhibitor showing histologic protection in human trials, and a $35M Takeda-funded oral enzyme program whose later trial stage reportedly worsened mucosal damage.

Contract fermentation manufacturers and specialty seasoning producers supply food brands with fermented bases (yeast extract, enzyme-assisted seasonings, amazake, cultured dairy/soy fractions) as B2B ingredients rather than finished consumer products.

B2B food-grade biopolymers — modified starches, plant-protein isolates and hydrocolloids — produced by reactive extrusion, wet fractionation and isopropanol precipitation for texture, structure and clean-label formulation across the food industry.

Dedicated food-tech venture funds, corporate open-innovation accelerators and government incubators form the connective infrastructure that scales new food bioeconomy technology across every specific vertical — the meta-layer that sources, funds and fast-tracks the innovations covered elsewhere in this catalog.

Live bacteria, yeast and mold cultures that kickstart dairy, bakery and brewing fermentation are a mature, still-growing global industry — Novonesis reported 7% Q1 2026 growth led by cheese, IFF's new culture eliminates all curd-washing water, and India's national dairy board now supplies indigenous starter cultures to its largest cooperatives.

Caffeine-and-L-theanine nootropic gum, melatonin sleep meltaways and hydroxyapatite whitening chews turn the stick of gum into an oral-delivery platform — Neuro Gum's DTC energy/focus line, Brew Chew's plastic-free whitening chicle, and Fertin Pharma's contract-manufactured nutraceutical gum built on specialty gum-base suppliers like Cafosa.

Personalized-nutrition platforms, postbiotic ingredient innovation and challenger clean-label supplement brands are reshaping functional foods from a generic wellness category into claims-substantiated, life-stage-targeted products — with consolidation already underway (Hindustan Unilever's $90M OZiva acquisition).

Microbial food protein grown by feeding hydrogen-oxidising bacteria a mix of hydrogen, CO2 and oxygen in gas-loop bioreactors — a land-free 'food from air' route now at commercial demonstration scale.

Precision-fermented human milk oligosaccharides — 2'-fucosyllactose, LNnT and sialylated sugars produced by engineered E. coli or yeast — that feed infant-formula bifidobacteria and block pathogen attachment, now expanding from infant nutrition into adult gut-health supplements.

Industrial-scale black soldier fly and mealworm farming is going through a hard correction in 2026 — a flagship European originator collapsed into insolvency and a flagship North American cricket plant entered receivership — even as an Indian entrant reports fast, capital-efficient growth.

Cricket bars, mealworm snacks, cricket pasta and chips — high-protein (~65%) insect-based snacks positioned on a fraction of the land, water and feed of conventional protein, led by a consolidated European specialist-brand set (Jimini's, Crické, Seek, Sens) and Chapul after several US high-profile failures.

Aspergillus oryzae solid-state fermentation of steamed grain into koji, shio-koji, miso and amazake bases — sold as finished consumer flavor starters by Clearspring (UK organic miso), Omsom (Asian flavor starter kits, DayDayCook-acquired), Toiro (premium Japanese miso import), Umami Cartel (shio-koji) and South River Miso (craft handmade American miso since 1982).

Kefir, water kefir, kvass and jun — live probiotic fermented drinks beyond kombucha, riding gut-health demand across the US, Europe, China and India, from Lifeway's drinkable kefir and KeVita's sparkling probiotic water to Yakult's lactobacillusdaily-dose category.

Conventional meat processors blending animal protein with pea, soy and chickpea isolates into 50/50 hybrid sausages, schnitzel, nuggets and meatballs — the flexitarian FMCG carve-out pioneered by Rügenwalder's Halb & Halb, now spreading to Perdue, Maple Leaf and Tyson as the hybrid meat market heads toward USD 1.68 bn by 2036.

Genetically engineered food crops — pea, potato, soybean, tobacco — are being turned into biofactories for specific animal-identical proteins (myoglobin, ovalbumin, casein, thaumatin), aiming to reach USDA/FDA and EFSA approval as a plant-grown alternative to fermentation or cell culture.

Fungal biomass protein (mycoprotein) and mycelium materials produced via fermentation of Fusarium, Neurospora and Trichoderma — a $4.6B market growing at 12% CAGR.

Dealcoholized brewing and distilled botanical spirit-alternatives that reproduce the adult-beverage occasion without ethanol — Athletic Brewing (the largest US dedicated NA brewer, dealcoholized Run Wild IPA), Seedlip (the world's first distilled NA spirit, Diageo-owned), Three Spirit (functional botanical elixirs), Ghia (bitter citrus apéritif) and Lyre's (the broadest NA spirit portfolio, Australia).

Enzymatic interesterification, degumming and fat-splitting are replacing chemical processing steps across the conventional edible-oil industry — Novonesis's Quara Supreme recovers 2% more yield in vegetable-oil degumming, and a new Novonesis/Thyssenkrupp Uhde process cuts the energy needed for fatty-acid production.

Genetically engineered microbes as cell factories for proteins, enzymes, HMOs and flavors — a stack from strain design to purified ingredient, at 30–50 g/L target titers.

Recombinant whey, casein and egg-white proteins produced by engineered yeast and filamentous fungi, cutting GHG emissions 90–97% and water use 95–99% versus animal farming.

Microbially fermented fats and oils for food — high-smoke-point fermented cooking oils, microalgae EPA/DHA omega-3 oils, animal-free flavor fats for plant-based meat and dairy, and cocoa-butter-equivalent microbial fats — produced by precision fermentation rather than crops or animals.

Engineered yeast and fungi now express the bioactive milk proteins — above all lactoferrin, the iron-binding 'pink gold' that is just 1 percent of whey and historically over 650 US dollars a kilo — that close the gap between infant formula and breast milk, with the first US FDA GRAS no-questions letters (TurtleTree 2025, All G 2026) and the Nestlé-Helaina and Novonesis-TurtleTree partnerships moving precision-fermented ingredients from B2B supply into finished early-life nutrition.

Species-specific probiotics and heat-stable postbiotics for dog and cat gut health — a $3.2B market driven by pet humanisation, growing at 11% CAGR.

Enzymatic epimerization turns commodity starch and fructose into allulose and tagatose — naturally occurring low-calorie sugars with sugar-like taste — while a separate fermentation route delivers stevia-derived sweeteners, moving allulose from 'unicorn ingredient' to commercial reality.

Roasted nori snacks, seaweed chips, kelp burgers and umami seasonings turning macroalgae into a mainstream better-for-you food category — dominated by China's multi-billion-yuan 海苔 market, with US and European premium brands riding iodine, omega-3 and clean-label demand.

Biological inputs are reshaping the conventional cane and beet sugar industry at both ends of the field — a sugarcane biostimulant lifting yields over 15% in India, and Brazilian enzyme cocktails converting sugarcane bagasse into the world's largest second-generation ethanol plant.

Precision fermentation is scaling up intensely sweet, calorie-free plant proteins as sugar replacements — a US platform's third FDA no-questions letter for brazzein, Europe's first commercial-scale brazzein factory under construction in Lithuania, and an Israeli engineered sweet protein clearing FDA GRAS and Singapore approval with published blood-glucose safety data.

Genomics and starter-culture fermentation are entering the world's oldest beverage crop — a Chinese gene chip mapping 3,274 tea-plant markers, a patented yeast strain industrializing Pu-erh flavor, and a Kenya field trial breeding drought-resistant cultivars under a multi-million-euro research partnership.

Kraut, kimchi and pickle makers rooted in decades- or centuries-old technique are scaling into mainstream retail — Walmart is betting big on fresh fermented foods with Cleveland Kitchen leading the charge, while Europe's largest sauerkraut factory reports surging global demand.

Industrial-scale vitamin manufacturing — B-group vitamins by direct fermentation, vitamin C by two-stage bioconversion of glucose, and vitamin D3 by UV photochemistry — concentrated overwhelmingly in China for bulk ascorbic acid while the EU retains unique fermentation capacity for riboflavin and stability-engineered feed premixes.

The microbial layer of winemaking — selected Saccharomyces wine yeasts, malolactic bacteria, microbial biocontrol tools and vineyard terroir-microbiome science that translate a vineyard's microbial identity (terroir) into controlled, expressive fermentation.